Literature DB >> 2332481

Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strains.

C C Sanders, S J Cavalieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2332481      PMCID： PMC267813          DOI： 10.1128/jcm.28.4.830-831.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  7 in total

1.  Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.

Authors:  P C Fuchs; R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

2.  Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.

Authors:  L Verbist; J Verhaegen
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

3.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

4.  A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.

Authors:  B Joly; M Chanal; D Sirot; M Cluzel; J Sirot; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

5.  Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.

Authors:  C C Sanders; J P Iaconis; G P Bodey; G Samonis
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

6.  In vitro activity and disk susceptibility of Timentin: current status.

Authors:  P C Fuchs; A L Barry; R N Jones
Journal:  Am J Med       Date:  1985-11-29       Impact factor: 4.965

7.  Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.

Authors:  R J Fass; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191
  7 in total
  1 in total

Review 1.  Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.

Authors:  J A Washington
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.